| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.97 | 0.002 | 0.97 | Aldehyde oxidase inhibitor | 0.164 0.127 CHEMBL3542270 0.169 0.124 CHEMBL3542312 0.219 0.095 CHEMBL3542324 | ||
| 0.969 | 0.004 | 0.969 | Analgesic | 0.352 0.107 CHEMBL3542324 | ||
| 0.93 | 0.002 | 0.93 | Analgesic, opioid | |||
| 0.861 | 0.004 | 0.861 | Spasmolytic | 0.203 0.117 CHEMBL3542270 0.388 0.043 CHEMBL3542324 | ||
| 0.776 | 0.003 | 0.776 | P-glycoprotein inhibitor | |||
| 0.738 | 0.005 | 0.738 | Hypoglycemic | |||
| 0.674 | 0.009 | 0.761 | 5 Hydroxytryptamine release stimulant | 0.726 0.005 CHEMBL3542270 0.581 0.016 CHEMBL3542312 0.761 0.004 CHEMBL3542324 | CHEMBL3542324 | |
| 0.655 | 0.005 | 0.655 | Potassium channel (Voltage-sensitive) blocker | 0.166 0.125 CHEMBL3542270 0.316 0.045 CHEMBL3542324 | ||
| 0.646 | 0.004 | 0.646 | Glutamate receptor antagonist | |||
| 0.639 | 0.006 | 0.639 | HERG channel blocker | 0.154 0.127 CHEMBL3542270 0.322 0.044 CHEMBL3542324 | ||
| 0.615 | 0.005 | 0.615 | Psychostimulant | 0.257 0.056 CHEMBL3542270 0.185 0.089 CHEMBL3542312 0.424 0.019 CHEMBL3542324 | ||
| 0.557 | 0.003 | 0.557 | Opioid agonist | |||
| 0.557 | 0.003 | 0.557 | Opioid mu receptor agonist | |||
| 0.555 | 0.004 | 0.555 | Opioid antagonist | 0.098 0.049 CHEMBL3542324 | ||
| 0.546 | 0.004 | 0.546 | Cholinergic antagonist | 0.221 0.027 CHEMBL3542270 0.325 0.012 CHEMBL3542312 0.279 0.017 CHEMBL3542324 | ||
| 0.54 | 0.004 | 0.54 | Opioid mu receptor antagonist | 0.061 0.053 CHEMBL3542324 | ||
| 0.537 | 0.004 | 0.537 | Acetylcholine antagonist | 0.217 0.027 CHEMBL3542270 0.323 0.012 CHEMBL3542312 0.274 0.017 CHEMBL3542324 | ||
| 0.498 | 0.011 | 0.5 | Potassium channel blocker | 0.342 0.034 CHEMBL3542270 0.5 0.011 CHEMBL3542324 | CHEMBL3542324 | |
| 0.454 | 0.004 | 0.454 | Acetylcholine nicotinic antagonist | 0.201 0.013 CHEMBL3542270 0.363 0.005 CHEMBL3542312 0.273 0.008 CHEMBL3542324 | ||
| 0.396 | 0.004 | 0.396 | Opioid kappa receptor antagonist | 0.075 0.065 CHEMBL3542324 | ||
| 0.335 | 0.004 | 0.335 | Neuronal nicotinic receptor antagonist | 0.144 0.013 CHEMBL3542270 0.299 0.005 CHEMBL3542312 0.195 0.008 CHEMBL3542324 | ||
| 0.353 | 0.025 | 0.353 | 5 Hydroxytryptamine uptake stimulant | 0.289 0.051 CHEMBL3542270 0.25 0.08 CHEMBL3542312 0.333 0.031 CHEMBL3542324 | ||
| 0.318 | 0.005 | 0.318 | NMDA receptor antagonist | |||
| 0.291 | 0.005 | 0.291 | Opioid delta receptor antagonist | |||
| 0.288 | 0.014 | 0.288 | Anesthetic local | 0.109 0.075 CHEMBL3542270 0.201 0.032 CHEMBL3542324 | ||
| 0.278 | 0.004 | 0.278 | Opioid delta receptor agonist | |||
| 0.258 | 0.047 | 0.258 | Anesthetic general | 0.155 0.108 CHEMBL3542270 0.134 0.132 CHEMBL3542312 0.196 0.077 CHEMBL3542324 | ||
| 0.347 | 0.148 | 0.347 | Caspase 9 stimulant | 0.273 0.226 CHEMBL3542312 0.292 0.203 CHEMBL3542324 | ||
| 0.255 | 0.064 | 0.31 | Tyrosine 3 hydroxylase inhibitor | 0.289 0.039 CHEMBL3542270 0.267 0.053 CHEMBL3542312 0.31 0.029 CHEMBL3542324 | CHEMBL3542324 | |
| 0.327 | 0.137 | 0.327 | 5 Hydroxytryptamine release inhibitor | 0.29 0.177 CHEMBL3542312 | ||
| 0.208 | 0.022 | 0.208 | Acetylcholine muscarinic antagonist | 0.116 0.071 CHEMBL3542270 0.185 0.028 CHEMBL3542324 | ||
| 0.177 | 0.005 | 0.177 | Androgen agonist | 0.069 0.032 CHEMBL3542270 0.059 0.042 CHEMBL3542312 0.096 0.016 CHEMBL3542324 | ||
| 0.272 | 0.113 | 0.272 | Vasodilator, coronary | 0.22 0.163 CHEMBL3542324 | ||
| 0.207 | 0.051 | 0.209 | 5 Hydroxytryptamine 3E antagonist | 0.199 0.064 CHEMBL3542270 0.209 0.049 CHEMBL3542312 0.207 0.052 CHEMBL3542324 | CHEMBL3542312 | |
| 0.28 | 0.13 | 0.384 | GABA C receptor rho-3 antagonist | 0.354 0.083 CHEMBL3542270 0.341 0.09 CHEMBL3542312 0.384 0.069 CHEMBL3542324 | CHEMBL3542324 | |
| 0.172 | 0.033 | 0.172 | Cathepsin H inhibitor | 0.103 0.102 CHEMBL3542312 | ||
| 0.162 | 0.026 | 0.162 | Falcipain inhibitor | |||
| 0.166 | 0.03 | 0.166 | Falcipain 3 inhibitor | |||
| 0.184 | 0.049 | 0.184 | Arachidonic acid antagonist | 0.148 0.091 CHEMBL3542312 0.137 0.104 CHEMBL3542324 | ||
| 0.158 | 0.025 | 0.158 | Falcipain 2 inhibitor | |||
| 0.271 | 0.14 | 0.271 | Histamine release inhibitor | |||
| 0.219 | 0.095 | 0.219 | DNA synthesis inhibitor | 0.186 0.145 CHEMBL3542324 | ||
| 0.31 | 0.199 | 0.361 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.309 0.201 CHEMBL3542270 0.361 0.139 CHEMBL3542312 0.332 0.172 CHEMBL3542324 | CHEMBL3542312 | |
| 0.169 | 0.059 | 0.241 | Acetylcholine M1 receptor antagonist | 0.158 0.067 CHEMBL3542270 0.241 0.027 CHEMBL3542324 | CHEMBL3542324 | |
| 0.157 | 0.054 | 0.157 | Neurotrophic factor | |||
| 0.175 | 0.076 | 0.198 | Lipocortins synthesis antagonist | 0.188 0.065 CHEMBL3542270 0.151 0.103 CHEMBL3542312 0.198 0.058 CHEMBL3542324 | CHEMBL3542324 | |
| 0.15 | 0.054 | 0.15 | Nav1.6 sodium channel blocker | |||
| 0.213 | 0.129 | 0.264 | Gastrin inhibitor | 0.229 0.106 CHEMBL3542270 0.203 0.145 CHEMBL3542312 0.264 0.064 CHEMBL3542324 | CHEMBL3542324 | |
| 0.167 | 0.084 | 0.167 | Succinate dehydrogenase inhibitor | 0.139 0.134 CHEMBL3542312 | ||
| 0.118 | 0.036 | 0.118 | Calcium antagonist | |||
| 0.14 | 0.061 | 0.14 | Alpha-N-acetylglucosaminidase inhibitor | 0.125 0.073 CHEMBL3542312 0.12 0.077 CHEMBL3542324 | ||
| 0.142 | 0.066 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.143 0.062 CHEMBL3542270 0.14 0.074 CHEMBL3542312 0.15 0.042 CHEMBL3542324 | CHEMBL3542324 | |
| 0.1 | 0.024 | 0.1 | Estrogen-related receptor beta agonist | 0.084 0.055 CHEMBL3542324 | ||
| 0.221 | 0.147 | 0.298 | Cholesterol antagonist | 0.254 0.122 CHEMBL3542270 0.214 0.153 CHEMBL3542312 0.298 0.092 CHEMBL3542324 | CHEMBL3542324 | |
| 0.123 | 0.051 | 0.123 | Aminopeptidase B inhibitor | |||
| 0.224 | 0.153 | 0.224 | Apoptosis antagonist | |||
| 0.194 | 0.124 | 0.194 | Superoxide dismutase inhibitor | 0.173 0.152 CHEMBL3542312 | ||
| 0.11 | 0.046 | 0.145 | Prolactin inhibitor | 0.127 0.034 CHEMBL3542270 0.084 0.074 CHEMBL3542312 0.145 0.024 CHEMBL3542324 | CHEMBL3542324 | |
| 0.101 | 0.042 | 0.101 | Glutamate release inhibitor | |||
| 0.108 | 0.051 | 0.108 | Sphingomyelinase inhibitor | |||
| 0.078 | 0.021 | 0.078 | Acetyl-CoA transferase inhibitor | |||
| 0.191 | 0.136 | 0.191 | Neuropeptide Y2 antagonist | |||
| 0.116 | 0.062 | 0.116 | Photosensitizer | 0.103 0.082 CHEMBL3542312 0.101 0.086 CHEMBL3542324 | ||
| 0.108 | 0.056 | 0.108 | Adenylate kinase inhibitor | |||
| 0.069 | 0.018 | 0.138 | Nicotinic alpha3beta2 receptor antagonist | 0.069 0.018 CHEMBL3542270 0.058 0.029 CHEMBL3542312 0.138 0.004 CHEMBL3542324 | CHEMBL3542324 | |
| 0.076 | 0.026 | 0.076 | Caspase 9 inhibitor | |||
| 0.117 | 0.068 | 0.117 | Calcium channel N-type blocker | |||
| 0.136 | 0.089 | 0.136 | Adenylate cyclase stimulant | |||
| 0.211 | 0.164 | 0.249 | Vasodilator, peripheral | 0.203 0.172 CHEMBL3542270 0.192 0.186 CHEMBL3542312 0.249 0.128 CHEMBL3542324 | CHEMBL3542324 | |
| 0.103 | 0.058 | 0.103 | Anabolic | 0.088 0.083 CHEMBL3542270 0.1 0.063 CHEMBL3542312 0.1 0.062 CHEMBL3542324 | ||
| 0.123 | 0.08 | 0.123 | Vanilloid 1 agonist | |||
| 0.07 | 0.027 | 0.07 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.112 | 0.07 | 0.112 | Microtubule formation inhibitor | |||
| 0.049 | 0.008 | 0.049 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.098 | 0.056 | 0.098 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.091 0.064 CHEMBL3542312 | ||
| 0.082 | 0.041 | 0.082 | Aminopeptidase I inhibitor | |||
| 0.064 | 0.025 | 0.064 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.173 | 0.137 | 0.173 | Immunostimulant | |||
| 0.051 | 0.017 | 0.051 | G protein-coupled receptor agonist | |||
| 0.16 | 0.126 | 0.16 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.102 | 0.069 | 0.152 | Ferrochelatase inhibitor | 0.129 0.048 CHEMBL3542270 0.129 0.048 CHEMBL3542312 0.152 0.037 CHEMBL3542324 | CHEMBL3542324 | |
| 0.035 | 0.006 | 0.035 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.112 | 0.084 | 0.121 | Nav1.3 sodium channel blocker | 0.121 0.073 CHEMBL3542324 | CHEMBL3542324 | |
| 0.194 | 0.166 | 0.203 | Insulysin inhibitor | 0.203 0.152 CHEMBL3542324 | CHEMBL3542324 | |
| 0.076 | 0.049 | 0.076 | Glutamate dehydrogenase inhibitor | |||
| 0.115 | 0.089 | 0.132 | Nav1.2 sodium channel blocker | 0.107 0.1 CHEMBL3542270 0.132 0.071 CHEMBL3542324 | CHEMBL3542324 | |
| 0.075 | 0.05 | 0.075 | Vanilloid 4 agonist | 0.072 0.06 CHEMBL3542324 | ||
| 0.103 | 0.08 | 0.119 | Acetylcholine release stimulant | 0.108 0.07 CHEMBL3542270 0.106 0.074 CHEMBL3542312 0.119 0.05 CHEMBL3542324 | CHEMBL3542324 | |
| 0.062 | 0.038 | 0.062 | Cathepsin E inhibitor | |||
| 0.033 | 0.011 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.092 | 0.069 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.17 | 0.148 | 0.17 | Calpain inhibitor | |||
| 0.091 | 0.07 | 0.091 | Creatine kinase inhibitor | 0.083 0.082 CHEMBL3542324 | ||
| 0.088 | 0.067 | 0.088 | Uric acid excretion stimulant | |||
| 0.058 | 0.038 | 0.058 | Argininosuccinate synthase inhibitor | |||
| 0.038 | 0.018 | 0.038 | Histone deacetylase 4 inhibitor | |||
| 0.034 | 0.018 | 0.034 | Peptide deformylase inhibitor | |||
| 0.039 | 0.024 | 0.085 | Nicotinic receptor beta4 subunit antagonist | 0.035 0.028 CHEMBL3542270 0.085 0.008 CHEMBL3542324 | CHEMBL3542324 | |
| 0.035 | 0.022 | 0.035 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.071 | 0.058 | 0.071 | CYP2A6 inhibitor | |||
| 0.082 | 0.07 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.07 CHEMBL3542312 | ||
| 0.088 | 0.076 | 0.088 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.034 | 0.023 | 0.034 | Histone deacetylase 2 inhibitor | |||
| 0.045 | 0.035 | 0.045 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.03 | 0.02 | 0.03 | Histone deacetylase 10 inhibitor | |||
| 0.064 | 0.055 | 0.064 | Elastase 1 inhibitor | |||
| 0.139 | 0.13 | 0.139 | Phospholipase C inhibitor | |||
| 0.06 | 0.052 | 0.06 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.067 | 0.059 | 0.067 | Phospholipase D inhibitor | |||
| 0.022 | 0.014 | 0.022 | Vitamin D receptor antagonist | |||
| 0.038 | 0.03 | 0.038 | Cathepsin L2 inhibitor | |||
| 0.068 | 0.06 | 0.141 | Acetylcholine M4 receptor antagonist | 0.108 0.023 CHEMBL3542270 0.141 0.012 CHEMBL3542324 | CHEMBL3542324 | |
| 0.025 | 0.018 | 0.025 | Vanilloid 2 agonist | |||
| 0.055 | 0.048 | 0.071 | Acetylcholine M3 receptor antagonist | 0.071 0.031 CHEMBL3542324 | CHEMBL3542324 | |
| 0.039 | 0.034 | 0.039 | Kainate receptor agonist | |||
| 0.049 | 0.044 | 0.049 | Human rhinovirus A protease inhibitor | |||
| 0.161 | 0.157 | 0.195 | Interleukin agonist | 0.168 0.151 CHEMBL3542312 0.195 0.125 CHEMBL3542324 | CHEMBL3542324 | |
| 0.026 | 0.023 | 0.026 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.022 | 0.019 | 0.022 | Histone deacetylase 3 inhibitor | |||
| 0.027 | 0.025 | 0.027 | Histone deacetylase class IV inhibitor | |||
| 0.027 | 0.025 | 0.027 | Histone deacetylase 11 inhibitor | |||
| 0.025 | 0.024 | 0.025 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.092 | 0.091 | 0.129 | GABA C receptor antagonist | 0.103 0.074 CHEMBL3542270 0.129 0.044 CHEMBL3542312 0.118 0.054 CHEMBL3542324 | CHEMBL3542312 | |
| 0.063 | 0.062 | 0.063 | Catalase inhibitor | |||
| 0.122 | 0.122 | 0.134 | Pregnane X receptor agonist | 0.123 0.122 CHEMBL3542270 0.134 0.09 CHEMBL3542324 | CHEMBL3542324 | |
| 0.088 | 0.103 | 0.095 | DOPA decarboxylase inhibitor | 0.095 0.087 CHEMBL3542312 | CHEMBL3542312 | |
| 0.045 | 0.061 | 0.11 | Acetylcholine M2 receptor antagonist | 0.059 0.046 CHEMBL3542270 0.11 0.019 CHEMBL3542324 | CHEMBL3542324 | |
| 0.033 | 0.051 | 0.115 | Glycine transporter inhibitor | 0.115 0.009 CHEMBL3542324 | CHEMBL3542324 | |
| 0.057 | 0.074 | 0.076 | Glutamate (mGluR7) antagonist | 0.069 0.044 CHEMBL3542270 0.076 0.033 CHEMBL3542324 | CHEMBL3542324 | |
| 0.136 | 0.161 | 0.146 | Neurotrophic factor enhancer | 0.146 0.144 CHEMBL3542312 | CHEMBL3542312 | |
| 0.062 | 0.093 | 0.081 | Glycine receptor antagonist | 0.072 0.07 CHEMBL3542312 0.081 0.055 CHEMBL3542324 | CHEMBL3542324 | |
| 0.029 | 0.069 | 0.075 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.034 CHEMBL3542270 0.075 0.014 CHEMBL3542324 | CHEMBL3542324 | |
| 0.027 | 0.068 | 0.048 | Guanylate cyclase inhibitor | 0.048 0.023 CHEMBL3542312 0.04 0.033 CHEMBL3542324 | CHEMBL3542312 | |
| 0.007 | 0.052 | 0.018 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 CHEMBL3542270 0.018 0.008 CHEMBL3542324 | CHEMBL3542324 | |
| 0.109 | 0.154 | 0.173 | GABA C receptor rho-2 antagonist | 0.162 0.059 CHEMBL3542270 0.172 0.049 CHEMBL3542312 0.173 0.048 CHEMBL3542324 | CHEMBL3542324 | |
| 0.147 | 0.195 | 0.327 | 5 Hydroxytryptamine 1E antagonist | 0.327 0.016 CHEMBL3542270 0.259 0.065 CHEMBL3542312 0.315 0.021 CHEMBL3542324 | CHEMBL3542270 | |
| 0.071 | 0.122 | 0.122 | GABA C receptor rho-1 antagonist | 0.104 0.057 CHEMBL3542270 0.122 0.038 CHEMBL3542312 0.116 0.043 CHEMBL3542324 | CHEMBL3542312 | |
| 0.037 | 0.091 | 0.102 | Acetylcholine M5 receptor antagonist | 0.07 0.031 CHEMBL3542270 0.102 0.017 CHEMBL3542324 | CHEMBL3542324 | |
| 0.032 | 0.086 | 0.13 | Dopamine uptake inhibitor | 0.051 0.047 CHEMBL3542270 0.13 0.013 CHEMBL3542324 | CHEMBL3542324 | |
| 0.066 | 0.127 | 0.101 | GABA C receptor agonist | 0.101 0.066 CHEMBL3542312 | CHEMBL3542312 | |
| 0.035 | 0.102 | 0.053 | Sphingosine kinase 2 inhibitor | 0.053 0.042 CHEMBL3542312 | CHEMBL3542312 | |
| 0.051 | 0.119 | 0.087 | Potassium channel (Tandem pore domain) blocker | 0.075 0.048 CHEMBL3542270 0.072 0.058 CHEMBL3542312 0.087 0.021 CHEMBL3542324 | CHEMBL3542324 | |
| 0.056 | 0.126 | 0.074 | Estrogen receptor alpha antagonist | 0.072 0.063 CHEMBL3542270 0.074 0.059 CHEMBL3542324 | CHEMBL3542324 | |
| 0.022 | 0.092 | 0.035 | Delayed rectifier potassium channel blocker | 0.035 0.03 CHEMBL3542324 | CHEMBL3542324 | |
| 0.033 | 0.104 | 0.052 | Cytokine production stimulant | 0.046 0.04 CHEMBL3542270 0.052 0.025 CHEMBL3542312 | CHEMBL3542312 | |
| 0.066 | 0.142 | 0.099 | Electrolyte absorption antagonist | 0.087 0.079 CHEMBL3542270 0.087 0.079 CHEMBL3542312 0.099 0.059 CHEMBL3542324 | CHEMBL3542324 | |
| 0.027 | 0.102 | 0.049 | 5 Hydroxytryptamine 2 agonist | 0.049 0.039 CHEMBL3542324 | CHEMBL3542324 | |
| 0.05 | 0.126 | 0.062 | Prolactin release inhibitor | 0.06 0.052 CHEMBL3542270 0.062 0.042 CHEMBL3542324 | CHEMBL3542324 | |
| 0.008 | 0.086 | 0.052 | Glycine transporter 1 inhibitor | 0.052 0.015 CHEMBL3542324 | CHEMBL3542324 | |
| 0.04 | 0.122 | 0.055 | Pregnane X receptor antagonist | 0.055 0.045 CHEMBL3542312 0.054 0.049 CHEMBL3542324 | CHEMBL3542312 | |
| 0.04 | 0.128 | 0.062 | Corticotropin releasing factor 2 receptor antagonist | 0.062 0.043 CHEMBL3542324 | CHEMBL3542324 | |
| 0.009 | 0.098 | 0.077 | Acetylcholine M4 receptor agonist | 0.077 0.006 CHEMBL3542324 | CHEMBL3542324 | |
| 0.004 | 0.094 | 0.022 | Immunosuppressant Cyclosporine-like | 0.022 0.003 CHEMBL3542324 | CHEMBL3542324 | |
| 0.028 | 0.12 | 0.059 | Alpha-mannosidase inhibitor | 0.059 0.028 CHEMBL3542324 | CHEMBL3542324 | |
| 0.1 | 0.195 | 0.136 | Interferon gamma antagonist | 0.136 0.1 CHEMBL3542312 0.127 0.117 CHEMBL3542324 | CHEMBL3542312 | |
| 0.046 | 0.149 | 0.167 | Acetylcholine agonist | 0.08 0.065 CHEMBL3542270 0.167 0.021 CHEMBL3542324 | CHEMBL3542324 | |
| 0.154 | 0.261 | 0.342 | Sodium/bile acid cotransporter inhibitor | 0.217 0.165 CHEMBL3542270 0.202 0.185 CHEMBL3542312 0.342 0.045 CHEMBL3542324 | CHEMBL3542324 | |
| 0.025 | 0.135 | 0.059 | Histamine agonist | 0.059 0.029 CHEMBL3542270 0.055 0.033 CHEMBL3542324 | CHEMBL3542270 | |
| 0.008 | 0.121 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.022 CHEMBL3542324 | CHEMBL3542324 | |
| 0.017 | 0.141 | 0.041 | Mannosidase inhibitor | 0.041 0.039 CHEMBL3542324 | CHEMBL3542324 | |
| 0.012 | 0.136 | 0.041 | Cholesterol ester transfer protein antagonist | 0.041 0.012 CHEMBL3542324 | CHEMBL3542324 | |
| 0.083 | 0.207 | 0.206 | Sigma receptor agonist | 0.159 0.079 CHEMBL3542270 0.206 0.06 CHEMBL3542324 | CHEMBL3542324 | |
| 0.075 | 0.199 | 0.115 | Protein kinase stimulant | 0.115 0.098 CHEMBL3542324 | CHEMBL3542324 | |
| 0.022 | 0.149 | 0.077 | Acetylcholine M5 receptor agonist | 0.066 0.049 CHEMBL3542270 0.077 0.037 CHEMBL3542324 | CHEMBL3542324 | |
| 0.051 | 0.179 | 0.144 | Alpha 2c adrenoreceptor antagonist | 0.113 0.055 CHEMBL3542270 0.144 0.035 CHEMBL3542324 | CHEMBL3542324 | |
| 0.004 | 0.134 | 0.029 | Sigma 2 receptor antagonist | 0.029 0.017 CHEMBL3542324 | CHEMBL3542324 | |
| 0.03 | 0.166 | 0.144 | Nicotinic alpha4beta2 receptor antagonist | 0.104 0.028 CHEMBL3542270 0.089 0.041 CHEMBL3542312 0.144 0.009 CHEMBL3542324 | CHEMBL3542324 | |
| 0.125 | 0.271 | 0.235 | RNA-directed DNA polymerase inhibitor | 0.21 0.086 CHEMBL3542270 0.214 0.081 CHEMBL3542312 0.235 0.06 CHEMBL3542324 | CHEMBL3542324 | |
| 0.018 | 0.174 | 0.106 | Dopamine transporter inhibitor | 0.106 0.01 CHEMBL3542324 | CHEMBL3542324 | |
| 0.02 | 0.177 | 0.077 | Nicotinic receptor alpha7 subunit antagonist | 0.056 0.034 CHEMBL3542270 0.077 0.018 CHEMBL3542324 | CHEMBL3542324 | |
| 0.111 | 0.272 | 0.131 | Heat shock protein 70 antagonist | 0.131 0.115 CHEMBL3542324 | CHEMBL3542324 | |
| 0.088 | 0.252 | 0.133 | CF transmembrane conductance regulator agonist | 0.133 0.111 CHEMBL3542312 | CHEMBL3542312 | |
| 0.006 | 0.171 | 0.036 | Endothelial nitric-oxide synthase inhibitor | 0.036 0.016 CHEMBL3542312 0.028 0.026 CHEMBL3542324 | CHEMBL3542312 | |
| 0.024 | 0.191 | 0.107 | Adrenaline uptake inhibitor | 0.056 0.049 CHEMBL3542270 0.107 0.017 CHEMBL3542324 | CHEMBL3542324 | |
| 0.031 | 0.211 | 0.057 | 5 Hydroxytryptamine 5A antagonist | 0.057 0.051 CHEMBL3542270 0.055 0.054 CHEMBL3542324 | CHEMBL3542270 | |
| 0.021 | 0.203 | 0.071 | Calcium channel T-type blocker | 0.071 0.027 CHEMBL3542324 | CHEMBL3542324 | |
| 0.006 | 0.19 | 0.043 | Imidazoline I1 receptor antagonist | 0.024 0.01 CHEMBL3542270 0.029 0.007 CHEMBL3542312 0.043 0.004 CHEMBL3542324 | CHEMBL3542324 | |
| 0.023 | 0.207 | 0.064 | Dopamine D1 antagonist | 0.064 0.046 CHEMBL3542324 | CHEMBL3542324 | |
| 0.016 | 0.202 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.024 CHEMBL3542312 | CHEMBL3542312 | |
| 0.011 | 0.198 | 0.13 | Acetylcholine muscarinic agonist | 0.048 0.045 CHEMBL3542270 0.13 0.013 CHEMBL3542324 | CHEMBL3542324 | |
| 0.026 | 0.219 | 0.088 | Androgen antagonist | 0.088 0.057 CHEMBL3542324 | CHEMBL3542324 | |
| 0.122 | 0.32 | 0.184 | Nitric-oxide synthase stimulant | 0.184 0.119 CHEMBL3542312 | CHEMBL3542312 | |
| 0.136 | 0.337 | 0.275 | Interleukin 2 agonist | 0.259 0.109 CHEMBL3542270 0.229 0.144 CHEMBL3542312 0.275 0.094 CHEMBL3542324 | CHEMBL3542324 | |
| 0.029 | 0.237 | 0.136 | Alpha 2 adrenoreceptor antagonist | 0.077 0.07 CHEMBL3542270 0.136 0.031 CHEMBL3542324 | CHEMBL3542324 | |
| 0.02 | 0.232 | 0.046 | Histamine H4 receptor antagonist | 0.046 0.039 CHEMBL3542324 | CHEMBL3542324 | |
| 0.065 | 0.277 | 0.104 | Transcription factor STAT6 inhibitor | 0.104 0.096 CHEMBL3542324 | CHEMBL3542324 | |
| 0.006 | 0.226 | 0.076 | Acetylcholine M1 receptor agonist | 0.038 0.035 CHEMBL3542270 0.076 0.017 CHEMBL3542324 | CHEMBL3542324 | |
| 0.137 | 0.358 | 0.26 | Ca(v)3.3 blocker | 0.247 0.106 CHEMBL3542270 0.24 0.117 CHEMBL3542312 0.26 0.086 CHEMBL3542324 | CHEMBL3542324 | |
| 0.044 | 0.272 | 0.088 | mTOR complex 2 inhibitor | 0.088 0.051 CHEMBL3542312 | CHEMBL3542312 | |
| 0.018 | 0.251 | 0.071 | Protein kinase C beta inhibitor | 0.071 0.046 CHEMBL3542324 | CHEMBL3542324 | |
| 0.035 | 0.272 | 0.091 | Nitric-oxide synthase inhibitor | 0.091 0.076 CHEMBL3542312 | CHEMBL3542312 | |
| 0.023 | 0.265 | 0.071 | Alpha 2a adrenoreceptor antagonist | 0.071 0.057 CHEMBL3542324 | CHEMBL3542324 | |
| 0.004 | 0.257 | 0.034 | Progesterone antagonist | 0.034 0.025 CHEMBL3542324 | CHEMBL3542324 | |
| 0.026 | 0.28 | 0.125 | Acetylcholine M3 receptor agonist | 0.081 0.059 CHEMBL3542270 0.125 0.032 CHEMBL3542324 | CHEMBL3542324 | |
| 0.006 | 0.27 | 0.062 | Potassium channel subfamily K member 3 blocker | 0.032 0.019 CHEMBL3542270 0.062 0.01 CHEMBL3542324 | CHEMBL3542324 | |
| 0.033 | 0.301 | 0.127 | 5 Hydroxytryptamine 3A agonist | 0.127 0.05 CHEMBL3542270 0.112 0.063 CHEMBL3542312 0.106 0.069 CHEMBL3542324 | CHEMBL3542270 | |
| 0.013 | 0.284 | 0.065 | 5 Hydroxytryptamine 1D antagonist | 0.065 0.044 CHEMBL3542324 | CHEMBL3542324 | |
| 0.021 | 0.306 | 0.091 | Inducible nitric-oxide synthase inhibitor | 0.091 0.046 CHEMBL3542312 0.074 0.073 CHEMBL3542324 | CHEMBL3542312 | |
| 0.022 | 0.318 | 0.068 | Secretase beta inhibitor | 0.068 0.053 CHEMBL3542324 | CHEMBL3542324 | |
| 0.01 | 0.331 | 0.061 | Acetylcholine M2 receptor agonist | 0.061 0.028 CHEMBL3542324 | CHEMBL3542324 | |
| 0.004 | 0.345 | 0.044 | Vascular adhesion protein 1 inhibitor | 0.044 0.021 CHEMBL3542324 | CHEMBL3542324 | |
| 0.029 | 0.378 | 0.082 | Antineoplastic alkaloid | 0.082 0.063 CHEMBL3542324 | CHEMBL3542324 | |
| 0.041 | 0.393 | 0.229 | Anticonvulsant | 0.229 0.065 CHEMBL3542324 | CHEMBL3542324 | |
| 0.007 | 0.366 | 0.179 | 5 Hydroxytryptamine uptake inhibitor | 0.179 0.013 CHEMBL3542324 | CHEMBL3542324 | |
| 0.009 | 0.374 | 0.055 | Cyclophilin A inhibitor | 0.055 0.005 CHEMBL3542324 | CHEMBL3542324 | |
| 0.031 | 0.41 | 0.138 | Bromodomain-containing protein 2 inhibitor | 0.136 0.014 CHEMBL3542270 0.109 0.031 CHEMBL3542312 0.138 0.013 CHEMBL3542324 | CHEMBL3542324 | |
| 0.017 | 0.401 | 0.064 | Orexin receptor antagonist | 0.064 0.05 CHEMBL3542324 | CHEMBL3542324 | |
| 0.006 | 0.426 | 0.077 | Nicotinic receptor alpha4 subunit antagonist | 0.077 0.014 CHEMBL3542324 | CHEMBL3542324 | |
| 0.016 | 0.449 | 0.069 | Orexin receptor 1 antagonist | 0.069 0.057 CHEMBL3542270 0.069 0.057 CHEMBL3542324 | CHEMBL3542324 | |
| 0.016 | 0.471 | 0.084 | Polo-like kinase-1 inhibitor | 0.084 0.074 CHEMBL3542324 | CHEMBL3542324 | |
| 0.001 | 0.463 | 0.018 | Calcineurin inhibitor | 0.018 0.004 CHEMBL3542324 | CHEMBL3542324 | |
| 0.005 | 0.482 | 0.041 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.041 0.039 CHEMBL3542324 | CHEMBL3542324 | |
| 0.007 | 0.491 | 0.035 | Tryptophan hydroxylase 1 inhibitor | 0.029 0.004 CHEMBL3542270 0.035 0.003 CHEMBL3542312 0.031 0.003 CHEMBL3542324 | CHEMBL3542312 | |
| 0.016 | 0.597 | 0.057 | Antiviral (Hepatitis D) | 0.057 0.025 CHEMBL3542324 | CHEMBL3542324 | |
| 0.077 | 0.658 | 0.168 | ErbB-1 antagonist | 0.159 0.156 CHEMBL3542270 0.168 0.137 CHEMBL3542324 | CHEMBL3542324 | |
| 0.008 | 0.603 | 0.067 | CXC chemokine 4 receptor antagonist | 0.067 0.038 CHEMBL3542324 | CHEMBL3542324 | |
| 0.016 | 0.625 | 0.193 | Polo-like kinase-2 inhibitor | 0.193 0.004 CHEMBL3542324 | CHEMBL3542324 | |
| 0.016 | 0.706 | 0.114 | Alpha 2d adrenoreceptor antagonist | 0.101 0.047 CHEMBL3542270 0.114 0.029 CHEMBL3542312 | CHEMBL3542312 | |
| 0.003 | 0.718 | 0.085 | CXC chemokine 3 receptor antagonist | 0.085 0.005 CHEMBL3542324 | CHEMBL3542324 | |
| 0.005 | 0.729 | 0.198 | CXC chemokine receptor antagonist | 0.198 0.005 CHEMBL3542324 | CHEMBL3542324 | |
| 0.004 | 0.76 | 0.061 | Bromodomain-containing protein 3 inhibitor | 0.061 0.019 CHEMBL3542270 0.053 0.029 CHEMBL3542312 0.057 0.024 CHEMBL3542324 | CHEMBL3542270 | |
| 0.003 | 0.821 | 0.048 | Dopamine D4 agonist | 0.048 0.038 CHEMBL3542324 | CHEMBL3542324 | |
| 0.007 | 0.852 | 0.274 | Polo-like kinase-3 inhibitor | 0.274 0.017 CHEMBL3542324 | CHEMBL3542324 | |
| 0.003 | 0.881 | 0.059 | Bromodomain-containing protein 4 inhibitor | 0.059 0.033 CHEMBL3542324 | CHEMBL3542324 | |
| 0.005 | 0.894 | 0.259 | Antiobesity | 0.259 0.148 CHEMBL3542324 | CHEMBL3542324 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |